GENEVA, July 18 -- REGENERON PHARMACEUTICALS, INC. filed a patent application (US2026/010773) for “METHODS OF TREATING FOOD ALLERGY BY ADMINISTERING AN IL-4R ANTAGONIST AND A BCMA TARGETING AGENT”. With publication no. WO/2026/151982, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 16/28

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....